PHARMING GRP SP. ADRS Tangible Net Worth Ratio
PHARMING GRP SP. ADRS tangible net worth ratio. PHARMING GRP SP. ADRS (PHG) has a Tangible Net Worth Ratio of 52.3% as of December 2025. This metric is calculated by deducting intangible assets (€132.22 Million) from net assets (€277.10 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore PHG shareholders equity momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of PHARMING GRP SP. ADRS (2021–2025)
Tangible net worth ratio of PHARMING GRP SP. ADRS from 2021 to 2025. This chart shows how PHARMING GRP SP. ADRS's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 52.3%, reflecting net assets of €277.10 Million with intangible assets of €132.22 Million EUR. Check PHARMING GRP SP. ADRS PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
PHARMING GRP SP. ADRS Tangible Net Worth Ratio by Year (2021–2025)
PHARMING GRP SP. ADRS tangible net worth ratio by year from 2021 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for PHARMING GRP SP. ADRS from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see how much is PHARMING GRP SP. ADRS worth.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 52.3% | €277.10 Million | €132.22 Million | €499.96 Million | ▼ -20.1 pp |
| 2024 | 72.4% | €221.06 Million | €61.04 Million | €399.99 Million | ▲ +5.0 pp |
| 2023 | 67.4% | €218.78 Million | €71.27 Million | €462.85 Million | ▲ +4.1 pp |
| 2022 | 63.3% | €204.64 Million | €75.12 Million | €425.80 Million | ▲ +6.7 pp |
| 2021 | 56.5% | €192.92 Million | €83.83 Million | €397.31 Million | — |